- Tytuł:
- Anti‐IL17A, Ixekizumab, for treatment‐resistant chronic venous leg ulcers: A phase II randomized, double‐blind, placebo‐controlled pilot trial.
- Autorzy:
- Źródło:
- Journal of the European Academy of Dermatology & Venereology. Aug2023, Vol. 37 Issue 8, pe973-e975. 3p.
Czasopismo naukowe